1. Comparative studies of insulin vs glucagon‐like peptide‐1 receptor agonists in patients initiating injectable therapy. Issue 2 (22nd November 2016) Authors: Dejgaard, Thomas Fremming; Madsbad, Sten Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 2(2017) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. (1st March 2019) Authors: Østergaard, Lauge; Mogensen, Ulrik M.; Bundgaard, Johan S.; Dahl, Anders; Wang, Andrew; Torp-Pedersen, Christian; Gislason, Gunnar; Køber, Lars; Køber, Nana; Dejgaard, Thomas Fremming; Frandsen, Christian Seerup; Fosbøl, Emil Loldrup Journal: International journal of cardiology Issue: Volume 278(2019) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial. Issue 3 (March 2016) Authors: Dejgaard, Thomas Fremming; Frandsen, Christian Seerup; Hansen, Tanja Stenbæk; Almdal, Thomas; Urhammer, Søren; Pedersen-Bjergaard, Ulrik; Jensen, Tonny; Jensen, Andreas Kryger; Holst, Jens Juul; Tarnow, Lise; Knop, Filip Krag; Madsbad, Sten; Andersen, Henrik Ullits Journal: Lancet Issue: Volume 4:Issue 3(2016) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes—a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study. Issue 4 (2nd April 2015) Authors: Dejgaard, Thomas Fremming; Knop, Filip Krag; Tarnow, Lise; Frandsen, Christian Seerup; Hansen, Tanja Stenbæk; Almdal, Thomas; Holst, Jens Juul; Madsbad, Sten; Andersen, Henrik Ullits Journal: BMJ open Issue: Volume 5:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emerging drugs for the treatment of obesity. (2nd January 2017) Authors: Martinussen, Christoffer; Bojsen-Moller, Kirstine Nyvold; Svane, Maria Saur; Dejgaard, Thomas Fremming; Madsbad, Sten Journal: Expert opinion on emerging drugs Issue: Volume 22:Number 1(2017:Mar.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes. Issue 6 (3rd June 2017) Authors: Østergaard, Lauge; Frandsen, Christian Seerup; Dejgaard, Thomas Fremming; Madsbad, Sten Journal: Expert review of clinical pharmacology Issue: Volume 10:Issue 6(2017) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liraglutide for treating type 1 diabetes. (2nd April 2016) Authors: Dejgaard, Thomas Fremming; Frandsen, Christian Seerup; Holst, Jens Juul; Madsbad, Sten Journal: Expert opinion on biological therapy Issue: Volume 16:Number 4(2016:Apr.) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. Issue 9 (September 2016) Authors: Frandsen, Christian Seerup; Dejgaard, Thomas Fremming; Madsbad, Sten Journal: Lancet Issue: Volume 4:Issue 9(2016) Page Start: 766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Non-insulin pharmacological therapies for treating type 1 diabetes. (13th June 2018) Authors: Frandsen, Christian Seerup; Dejgaard, Thomas Fremming; Madsbad, Sten; Holst, Jens Juul Journal: Expert opinion on pharmacotherapy Issue: Volume 19:Number 9(2018) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial. Issue 6 (27th June 2018) Authors: Johansen, Nicklas Järvelä; Dejgaard, Thomas Fremming; Lund, Asger; Vilsbøll, Tina; Andersen, Henrik Ullits; Knop, Filip Krag Journal: BMJ open Issue: Volume 8:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗